MMJ's ourney has only started, page-32

I'm not concerned with the vaporiser concept. There are companies like ESE whose sole focus is vaporising liquids. I don't think vaporising buds medicinally will take off. Recreationally, yes.
Competition is large and I wouldn't be surprised if we have put it on the back burner.

I think phytotech are concentrating on their clinical trials first and with that, the delivery method will come. This shit takes years.

In the meantime, MMJ is focusing on TSX listing , getting a sales license, and the Canadian recreational market. Also the pills in Oz, which will hopefully just us an income stream. Something most MM companies don't have.